Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients

NCT04750122 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Early Breast Cancer

Interventions

DRUG: neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screenning

Sponsor

Peking University People's Hospital